FOXO TECHNOLOGIES INC. Increase (Decrease) in Reinsurance Payables
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Reinsurance Payables of $18.57 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReinsurancePayables · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance payables for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance payables for the quarter ending 2022-12-31 was $181.00K, a 16.59% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance payables for the quarter ending 2021-12-31 was $217.00K.
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance payables for fiscal 2023 was $18.57M, a 1986.85% increase from fiscal 2022.
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance payables for fiscal 2022 was $890.00K, a 191.80% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. increase (decrease) in reinsurance payables for fiscal 2021 was $305.00K.
| Period end | Increase (Decrease) in Reinsurance Payables 3 month | Increase (Decrease) in Reinsurance Payables 9 month | Increase (Decrease) in Reinsurance Payables 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $18.57M 10-K · filed 2024-06-06 | |
| 2023-09-30 | $18.57M 10-Q/A · filed 2024-06-04 | ||
| 2022-12-31 | $181.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $890.00K 10-K · filed 2024-06-06 | |
| 2022-09-30 | $709.00K 10-Q/A · filed 2024-06-04 | ||
| 2021-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $305.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $88.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |